Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-9-25
pubmed:abstractText
In an attempt to improve the limited efficacy of treatment of chronic hepatitis C with interferon-alpha 3 MU tiw, we studied the effects of double-dose therapy followed by downward titration, and analyzed the pre- and pertreatment factors associated with response or non-response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
951-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9672169-Adult, pubmed-meshheading:9672169-Aged, pubmed-meshheading:9672169-Alanine Transaminase, pubmed-meshheading:9672169-Antiviral Agents, pubmed-meshheading:9672169-Aspartate Aminotransferases, pubmed-meshheading:9672169-Dose-Response Relationship, Drug, pubmed-meshheading:9672169-Drug Administration Schedule, pubmed-meshheading:9672169-Female, pubmed-meshheading:9672169-Follow-Up Studies, pubmed-meshheading:9672169-Genotype, pubmed-meshheading:9672169-Hepacivirus, pubmed-meshheading:9672169-Hepatitis C, Chronic, pubmed-meshheading:9672169-Humans, pubmed-meshheading:9672169-Injections, Subcutaneous, pubmed-meshheading:9672169-Interferon-alpha, pubmed-meshheading:9672169-Liver Cirrhosis, pubmed-meshheading:9672169-Male, pubmed-meshheading:9672169-Middle Aged, pubmed-meshheading:9672169-Probability, pubmed-meshheading:9672169-RNA, Viral, pubmed-meshheading:9672169-Recombinant Proteins, pubmed-meshheading:9672169-Time Factors
pubmed:year
1998
pubmed:articleTitle
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
pubmed:affiliation
Erasmus University Hospital-Dijkzigt, Rotterdam, The Netherlands. brouwer@inw2.azr.nl
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study